Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Emerging trends for pancreatitis in the scientific literature: a new report
Posted on October 19th, 2021 by Ann-Marie Roche in Pharma R&D
Elsevier has just released the Emerging trends for pancreatitis in the scientific literature report, which identifies proteins and genes linked to pancreatitis. Elsevier’s Professional Services team prepared it pro bono for Mission: Cure, a foundation that is focused on finding a disease-modifying treatment for pancreatitis. The team hopes that all researchers working on pancreatitis, which affects millions of people worldwide in both acute and chronic forms, will find it useful.
“The report distills vast amounts of scientific literature to identify biological concepts or potential targets for drug discovery that are increasingly found in recent publications,” said Eric J. Gilbert, a Life Sciences consultant at Elsevier who was instrumental in putting together the report.
This examination of emerging trends is a great example of how data science and analytics are now being used to support the life sciences and accelerate drug discovery. To create the report, text and data mining technologies were used to draw relevant information from Elsevier’s vast collection of scientific literature, and natural language processing also played a role in analyzing the data. Gilbert noted that “some data was also obtained from the National Center for Biotechnology Information (NCBI) databases.”
There are a number of interesting insights to be found in the report, which you can download here. Were there any insights that Gilbert himself found especially noteworthy?
“I was surprised that all of the identified terms or processes related to pancreatitis had been validated in animal in vivo studies,” he shared. “Several compounds are also in the clinic with the hope that the positive animal data will translate to humans.”
The report explores ongoing pancreatitis R&D, the biology and mechanisms of the disease, general knowledge gaps, and potential therapeutics, so there is plenty to uncover for both scientists who are already working on pancreatitis research and for those who want to better familiarize themselves with the disease.
“While this report focuses on pancreatitis, this type of analysis can be done for any disease of interest,” Gilbert noted.
If you would like to learn more about other reports like this that the Professional Services team has created, or to find out how they can help you, please visit their website.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Director, Corporate Markets Marketing, Elsevier
- Pharma can now track the most relevant patent info – fast and at scale
- Umesh Nandal: Chemist and data scientist in one
- AI-driven innovation in Life Sciences: Data Science & AI amplifies your innovative drug R&D capabilities
- AI precision medicine accelerates the search for rare disease treatment
- SciBite’s James Malone Talks Future of Biocuration on Conference Panel